Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
(2) Prof. Antonio Mastino, University of Messina, Italy And Institute of Translational Pharmacology, National Research Council, Italy.
(3) Prof. Abdullah Aydin, Kırşehir Ahi Evran University, Turkey.
Reviewers:
(1) Mamta Devi Sharma, Shoolini Institute of Life Sciences and Business Management, India.
(2) Mennat-Elrahman Ahmed Fahmy, Theodor Bilharz Research Institute, Egypt.
(3) Glad Mohesh M. I, Shri Sathya Sai Medical College & RI, India.
(4) Shoebul Haque, King George’s Medical University, India.
(5) Preeti Shanbhag, Srinivas College of Pharmacy, India.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Mamta Devi Sharma, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Mennat-Elrahman Ahmed Fahmy, Egypt) | File 1 | NA
Stage 2 | Peer Review Report_3 (Glad Mohesh M. I, India) | File 1 | NA
Stage 2 | Peer Review Report_4 (Shoebul Haque, India) | File 1 | NA
Stage 2 | Peer Review Report_5 (Preeti Shanbhag, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Comment_Editor_3_v1 | File 1 | File 2
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA